Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
5XHL
DownloadVisualize
BU of 5xhl by Molmil
Crystal Structure of HasAp with Gallium Phthalocyanine
Descriptor: Heme acquisition protein HasAp, Phthalocyanine containing GA
Authors:Shoji, O, Shisaka, Y, Iwai, Y, Sugimoto, H, Shiro, Y, Watanabe, Y.
Deposit date:2017-04-21
Release date:2017-12-06
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Crystal Structure of HasAp with Gallium Phthalocyanine
to be published
7DHL
DownloadVisualize
BU of 7dhl by Molmil
Crystal structure of FGFR3 in complex with pyrimidine derivative
Descriptor: 5-[2-(3,5-dimethoxyphenyl)ethyl]-N-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidin-2-amine, Fibroblast growth factor receptor 3
Authors:Echizen, Y, Tateishi, Y, Amano, Y.
Deposit date:2020-11-16
Release date:2021-02-03
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.57 Å)
Cite:Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency.
Bioorg.Med.Chem., 33, 2021
6LVL
DownloadVisualize
BU of 6lvl by Molmil
Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative
Descriptor: Fibroblast growth factor receptor 2, N-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide, SULFATE ION
Authors:Echizen, Y, Tateishi, Y, Amano, Y.
Deposit date:2020-02-04
Release date:2020-04-08
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.98 Å)
Cite:Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Bioorg.Med.Chem., 28, 2020
6LVM
DownloadVisualize
BU of 6lvm by Molmil
Crystal structure of FGFR3 in complex with pyrimidine derivative
Descriptor: 2-[[5-[2-(3,5-dimethoxyphenyl)ethyl]-2-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]pyrimidin-4-yl]amino]-N-ethyl-benzenesulfonamide, Fibroblast growth factor receptor 3
Authors:Echizen, Y, Tateishi, Y, Amano, Y.
Deposit date:2020-02-04
Release date:2020-04-08
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.53 Å)
Cite:Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Bioorg.Med.Chem., 28, 2020
6LVK
DownloadVisualize
BU of 6lvk by Molmil
Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative
Descriptor: Fibroblast growth factor receptor 2, N-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide, SULFATE ION
Authors:Echizen, Y, Amano, Y, Tateishi, Y.
Deposit date:2020-02-04
Release date:2020-04-08
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.29 Å)
Cite:Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Bioorg.Med.Chem., 28, 2020
1STC
DownloadVisualize
BU of 1stc by Molmil
CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
Descriptor: CAMP-DEPENDENT PROTEIN KINASE, PROTEIN KINASE INHIBITOR, STAUROSPORINE
Authors:Prade, L, Engh, R.A, Girod, A, Kinzel, V, Huber, R, Bossemeyer, D.
Deposit date:1997-10-10
Release date:1998-02-25
Last modified:2023-08-09
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Structure, 5, 1997

225158

PDB entries from 2024-09-18

PDB statisticsPDBj update infoContact PDBjnumon